Eppendorf
Eppendorf AG, a leading name in the life sciences industry, is headquartered in Hamburg, Germany (DE). Founded in 1945, the company has established itself as a pioneer in laboratory equipment and consumables, serving researchers and scientists across the globe. Eppendorf's core business areas include liquid handling, sample handling, and cell culture, with innovative products such as pipettes, centrifuges, and bioreactors that are renowned for their precision and reliability. With a strong presence in Europe, North America, and Asia, Eppendorf has achieved significant milestones, including numerous awards for product excellence and sustainability initiatives. The company is committed to advancing scientific research, making it a trusted partner in laboratories worldwide. Eppendorf's dedication to quality and innovation solidifies its position as a market leader in the life sciences sector.
DitchCarbon Score
How does Eppendorf's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eppendorf's score of 36 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eppendorf's reported carbon emissions
In 2022, Eppendorf reported total carbon emissions of approximately 700,900 kg CO2e for Scope 1, 1,805 kg CO2e for Scope 2 (market-based), and 246,561,000 kg CO2e for Scope 3 emissions, which includes significant contributions from the use of sold products. The company has set ambitious climate commitments, aiming for net-zero emissions by 2050. In the near term, Eppendorf targets a reduction of 95% of its Scope 1 and Scope 2 emissions and 67% of its Scope 3 emissions by 2030. Over the years, Eppendorf has demonstrated a commitment to reducing its carbon footprint, with total Scope 1 and 2 emissions reported at approximately 8,814 kg CO2e in 2022, down from about 20,946,000 kg CO2e in 2020. This reflects a proactive approach to sustainability within the pharmaceuticals and biotechnology sector, aligning with industry standards for climate action. The company is focused on achieving a long-term reduction of 90% across all scopes by 2050, reinforcing its dedication to environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 7,644,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 13,202,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 81,784,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eppendorf is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
